Intelligent Blood Collection Management Systems Market Report 2026

Intelligent Blood Collection Management Systems Market Overview

• Intelligent Blood Collection Management Systems market size has reached to $2.44 billion in 2025 • Expected to grow to $3.92 billion in 2030 at a compound annual growth rate (CAGR) of 10% • Growth Driver: Surge In Blood Donation Programs Fueling The Growth Of The Market Due To Increasing Awareness Campaign • Market Trend: Autonomous Robotic Phlebotomy Devices Advance Automation And Precision In Blood Collection Management • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Intelligent Blood Collection Management Systems Market?

Intelligent blood collection management systems are advanced healthcare solutions that integrate digital technologies to streamline and manage blood collection, sample tracking, labeling, storage, and workflow operations across hospitals, blood banks, and diagnostic laboratories. These systems are designed to minimize collection and identification errors, strengthen patient and donor safety, improve operational productivity, and ensure accurate blood inventory and transfusion management throughout the healthcare network. The main components of intelligent blood collection management systems include software, hardware, and services. Software refers to digital platforms that automate and optimize blood collection workflows, donor records, inventory tracking, and operational management. These systems are deployed through on premises and Cloud-Based models. They find application in blood collection management, donor management, inventory management, screening and testing, and others, serving end users including hospitals, blood banks, and research laboratories.

What Is The Intelligent Blood Collection Management Systems Market Growth Forecast?

The intelligent blood collection management systems market size is expected to see strong growth in the next few years. It will grow to $3.92 billion in 2030 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to increasing automation in clinical workflows, rising surgical and chronic disease driven blood demand, stricter global regulatory compliance requirements, growing need for real time blood inventory visibility, expansion of standardized transfusion safety protocols. Major trends in the forecast period include regulatory driven hemovigilance strengthening, cold chain optimization in blood storage logistics, interoperability standards for hospital and laboratory systems, centralized blood bank network consolidation, enhanced donor retention and engagement programs.

Global Intelligent Blood Collection Management Systems Market Segmentation

1) By Component: Software, Hardware, Services 2) By Deployment Mode: On Premises, Cloud-Based 3) By Application: Blood Collection Management, Donor Management, Inventory Management, Screening And Testing, Other Applications 4) By End User: Hospitals, Blood Banks, Research Laboratories Subsegments: 1) By Software: Donor Management Software, Blood Inventory Management Software, Appointment Scheduling Software, Data Analytics Software 2) By Hardware: Blood Collection Monitors, Hemoglobin Testing Devices, Barcode Scanners, Label Printers 3) By Services: Installation And Setup Services, Maintenance And Support Services, Training And Education Services, Consulting Services

What Is The Driver Of The Intelligent Blood Collection Management Systems Market?

The rise in blood donation programs is expected to propel the growth of the intelligent blood collection management systems market going forward. Blood donation programs refer to organized initiatives that encourage individuals to voluntarily donate blood to support medical treatments, emergency care, and healthcare systems. The rise in blood donation programs is driven by increasing awareness campaigns, as they encourage more individuals to donate blood regularly to support emergency care and medical treatments. Intelligent blood collection management systems help blood donation programs by streamlining donor registration, scheduling, blood tracking, and inventory management, improving operational efficiency and ensuring timely blood availability. For instance, in March 2026, according to the American Red Cross, a US-based humanitarian organization, over 25,000 blood donations were collected in the United States through a partnership initiated in 2025, contributing to nearly 40,000 donations. Therefore, a rise in blood donation programs is driving the growth of the intelligent blood collection management systems industry.

Key Players In The Global Intelligent Blood Collection Management Systems Market

Major companies operating in the intelligent blood collection management systems market are Abbott Laboratories, Roche Diagnostics International AG, Becton Dickinson and Company, Fresenius SE & Co. KGaA, Terumo Corporation, Grifols S.A., Haemonetics Corporation, Sysmex Corporation, Sarstedt AG & Co. KG, WellSky Corporation, Macopharma SA, Mak-System, Inpeco, Delcon S.r.l.

Global Intelligent Blood Collection Management Systems Market Trends and Insights

Major companies operating in the intelligent blood collection management systems market are focusing on developing advanced automated blood collection technologies, such as autonomous robotic phlebotomy devices, to enhance collection accuracy, improve patient experience, and streamline clinical workflow efficiency. Autonomous robotic phlebotomy devices are automated systems that use robotics, artificial intelligence, and imaging technologies to perform blood collection procedures with minimal human intervention. For instance, in March 2025, Vitestro, a Netherlands-based medical robotics company, unveiled Aletta, the world’s first autonomous robotic phlebotomy device. It is designed to support improved blood collection precision and operational efficiency. The system enables automated vein identification, robotic needle insertion, and standardized sample collection, strengthening workflow optimization and patient care in healthcare and diagnostic settings.

What Are Latest Mergers And Acquisitions In The Intelligent Blood Collection Management Systems Market?

In June 2024, Nightingale Health Plc, a Finland-based provider of disease risk detection and preventative health, acquired all intellectual property assets related to the Velvet blood collection device from RenegadeXBio, PBC, for an undisclosed amount. Through this acquisition, Nightingale Health aimed to strengthen its end-to-end intelligent blood collection management capabilities by transitioning from a license holder to the sole owner of the Velvet device, enabling full proprietary control over its integrated remote blood collection and analysis workflow. RenegadeXBio, PBC is a US-based biotechnology research company specializing in intelligent blood self-collection devices and diagnostic technologies, including the Velvet device.

Regional Outlook

North America was the largest region in the intelligent blood collection management systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Intelligent Blood Collection Management Systems Market?

The intelligent blood collection management systems market consists of revenues earned by entities by providing services such as donor data management, blood inventory tracking, sample identification and barcode labeling, and transfusion workflow monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The intelligent blood collection management systems market also includes sales of blood collection chairs, automated blood collection devices, and portable blood collection carts. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Intelligent Blood Collection Management Systems Market Report 2026?

The intelligent blood collection management systems market research report is one of a series of new reports from The Business Research Company that provides intelligent blood collection management systems market statistics, including intelligent blood collection management systems industry global market size, regional shares, competitors with a intelligent blood collection management systems market share, detailed intelligent blood collection management systems market segments, market trends and opportunities, and any further data you may need to thrive in the intelligent blood collection management systems industry. This intelligent blood collection management systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.